Bacillus Clausii Septicemia in a Pediatric Patient After Treatment With Probiotics

Pediatr Infect Dis J. 2019 Sep;38(9):e228-e230. doi: 10.1097/INF.0000000000002350.

Abstract

Isolated cases of septicemia associated with probiotics have been reported. We describe Bacillus clausii septicemia in a 4-month-old male infant with congenital heart disease following treatment for diarrhea with a probiotic containing B. clausii spores. The septicemia proved refractory to treatment with antibiotics active against the pathogen and progressed to multidrug-resistant sepsis with multiorgan failure.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacillus clausii / drug effects
  • Bacillus clausii / pathogenicity*
  • Diarrhea / therapy*
  • Drug Resistance, Multiple, Bacterial
  • Fatal Outcome
  • Humans
  • Infant
  • Male
  • Multiple Organ Failure / microbiology
  • Probiotics / adverse effects*
  • Sepsis / diagnosis*
  • Sepsis / drug therapy
  • Sepsis / etiology*
  • Sepsis / microbiology

Substances

  • Anti-Bacterial Agents